Generics News
-
Bayer leads Metagenomi complete $65M series A financing round
Generics | News | 0 Comment | 16 Nov, 2020
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...Read more
-
Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes
Generics | News | 0 Comment | 21 May, 2020
These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...Read more
-
Indian Pharma market to raise from US$34.3bn in 2020 to more than US$45bn by 2025
Generics | News | 0 Comment | 24 Feb, 2020
Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...Read more
-
Towa to acquire Esteve’s generic division for 320M euros
Generics | News | 0 Comment | 24 Dec, 2019
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...Read more
-
Panacea Biotec launches diabetes drug in India
Generics | News | 0 Comment | 11 Dec, 2019
Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...Read more
-
HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug
Generics | News | 2 Comment | 06 Dec, 2019
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...Read more
-
Eris Lifesciences acquires trademark Zomelis from Novartis for India market
Generics | News | 0 Comment | 04 Dec, 2019
Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...Read more
-
EMA and FDA accept marketing applications for Chugai's Satralizumab
Generics | News | 0 Comment | 31 Oct, 2019
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...Read more
-
Dr. Reddy’s confirms recall of all Ranitidine products
Generics | News | 0 Comment | 24 Oct, 2019
Dr. Reddy’s Laboratories along with its subsidiaries, together referred to as “Dr. Reddy’s confirms it...Read more
-
Eisai, Nichi-Iko explore generic pharma biz in China
Generics | News | 0 Comment | 01 Oct, 2019
Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...Read more
-
Glenmark receives approval from Russia to market Montlezir
Generics | News | 0 Comment | 30 Sep, 2019
Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...Read more
-
Glenmark receives Orphan Drug Designation for GBR 1342
Generics | News | 0 Comment | 17 Sep, 2019
Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...Read more
-
Lupin launches antidepressant drug
Generics | News | 0 Comment | 23 Aug, 2019
Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...Read more
-
Teva launches Epinephrine Injection in the US
Generics | News | 0 Comment | 21 Aug, 2019
Teva Pharmaceutical Industries has announced the availability of the FDA-approved generic version of EpiPen Jr®1&nbs...Read more
-
Sandoz launches oncology generic gefitinib in 13 EU countries
Generics | News | 0 Comment | 10 Jul, 2019
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...Read more
-
Teva announces launch of a generic version of Tracleer® in US
Generics | News | 0 Comment | 20 Jun, 2019
Teva Pharmaceutical Industries Ltd. has announced the launch of a generic version of Tracleer® (bosentan) tablets, 6...Read more
-
Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2)
Generics | News | 0 Comment | 05 Jun, 2019
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...Read more
-
GSK announces approval of Shingrix in China
Generics | News | 0 Comment | 27 May, 2019
GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...Read more
